Trials / Terminated
TerminatedNCT01406860
Droperidol Versus Metoclopramide + Diphenhydramine for the Treatment of Primary Headaches
Droperidol Versus Metoclopramide + Diphenhydramine for the Treatment of Primary Headaches in the Emergency Department: A Prospective Randomized, Double-blinded Trial.
- Status
- Terminated
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 19 (actual)
- Sponsor
- University of Iowa · Academic / Other
- Sex
- All
- Age
- 18 Years – 64 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to determine if droperidol is equally as effective as metoclopramide for treatment of primary headaches in the Emergency Department.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Droperidol | Droperidol 1.25 mg IV x 1, may repeat 0.625 mg if needed at 60 minutes |
| DRUG | Metoclopramide + diphenhydramine | Metoclopramide 20 mg IV infusion q30 minutes as needed with a maximum of 4 doses + Diphenhydramine 25 mg IV injection x 1 given with the first dose of metoclopramide IV infusion and repeated x 1 given with the third metoclopramide IV infusion. |
Timeline
- Start date
- 2011-07-01
- Primary completion
- 2012-07-01
- Completion
- 2012-07-01
- First posted
- 2011-08-01
- Last updated
- 2017-12-05
- Results posted
- 2017-12-05
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01406860. Inclusion in this directory is not an endorsement.